Inventor · disambiguated record
William N. Washburn
Also filed as: WASHBURN WILLIAM · WASHBURN WILLIAM N
45 granted patents·4 pending applications·2,558 citations·filing 1984–2013
98Inventor score
Files withBRISTOL MYERS SQUIBB CO24EASTMAN KODAK CO6STERLING WINTHROP INC4UNIV CALIFORNIA3DEVASTHALE PRATIK2
Top patents by PatentIndex Score
49 records- 0198US6515117B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 4, 2003·372 cites·17 claims
- 0298US6414126B1C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 2, 2002·380 cites·30 claims
- 0398US5770615ACatecholamine surrogates useful as β3 agonistsBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Jun 23, 1998·254 cites·23 claims
- 0497US6936590B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 30, 2005·133 cites·9 claims
- 0597US6683056B2O-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jan 27, 2004·145 cites·26 claims
- 0697US5541204AAryloxypropanolamine β 3 adrenergic agonistsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jul 30, 1996·269 cites·16 claims
- 0796US7589193B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 15, 2009·67 cites·15 claims
- 0896US6555519B2O-glucosylated benzamide SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Apr 29, 2003·129 cites·24 claims
- 0996US5776983ACatecholamine surrogates useful as β3 agonistsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jul 7, 1998·300 cites·14 claims
- 1096US5258407A3,4-disubstituted phenols-immunomodulating agentsSTERLING WINTHROP INC·Filed 1991·Granted Nov 2, 1993·92 cites·13 claims
- 1195US5466715A3,4-disubstituted phenols-immunomodulating agentsSTERLING WINTHROP INC·Filed 1994·Granted Nov 14, 1995·55 cites·12 claims
- 1293US7745447B2Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 29, 2010·28 cites·1 claims
- 1391US7365061B22-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 29, 2008·12 cites·7 claims
- 1490US8618115B2Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using themWASHBURN WILLIAM N·Filed 2006·Granted Dec 31, 2013·24 cites·14 claims
- 1588US7973159B2Non-basic melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jul 5, 2011·10 cites·20 claims
- 1688US7851622B2Non-basic melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 14, 2010·10 cites·20 claims
- 1786US8580959B2Azolotriazinone melanin concentrating hormone receptor-1 antagonistsDEVASTHALE PRATIK·Filed 2009·Granted Nov 12, 2013·18 cites·19 claims
- 1885US8012984B2Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methodsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Sep 6, 2011·7 cites·24 claims
- 1983US8088743B2Methods for treating obesity employing an SGLT2 inhibitorWASHBURN WILLIAM N·Filed 2008·Granted Jan 3, 2012·7 cites·7 claims
- 2083US5019492APhotographic element and process comprising a blocked photographically useful compoundEASTMAN KODAK CO·Filed 1989·Granted May 28, 1991·51 cites·8 claims
- 2183US4555477APhotographic element and process utilizing metal complex color masking dyesEASTMAN KODAK CO·Filed 1985·Granted Nov 26, 1985·16 cites·15 claims
- 2282US7989433B2Substituted thieno[3,2-D]pyrimidines as melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Aug 2, 2011·4 cites·18 claims
- 2382US6436914B12-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonistsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 20, 2002·12 cites·13 claims
- 2482US4557998AColorless ligand-releasing monomers and polymers and their use to provide dyes with metal ionsEASTMAN KODAK CO·Filed 1985·Granted Dec 10, 1985·16 cites·10 claims
- 2581US8067420B2Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methodsSTEIN PHILIP D·Filed 2011·Granted Nov 29, 2011·7 cites·17 claims
- 2679US7223786B22-aminonaphthalene derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·2 cites·7 claims
- 2775US9499482B2Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 22, 2016·2 cites·13 claims
- 2875US8415386B2Azolopyrrolone melanin concentrating hormone receptor-1 antagonistsDEVASTHALE PRATIK·Filed 2009·Granted Apr 9, 2013·3 cites·20 claims
- 2972US8344160B2Pyrrolone melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Jan 1, 2013·2 cites·13 claims
- 3068US8883743B2Methods for treating obesity employing an SGLT2 inhibitorWASHBURN WILLIAM·Filed 2011·Granted Nov 11, 2014·2 cites·8 claims
- 3164US5427919AHydrolytic enzyme inhibitors/inactivators and methods for using sameUNIV CALIFORNIA·Filed 1993·Granted Jun 27, 1995·28 cites·2 claims
- 3264US5310760A3,4-disubstituted anilines-immunomodulating agentsSTERLING WINTHROP INC·Filed 1993·Granted May 10, 1994·24 cites·8 claims
- 3363US5723489AAryloxypropanolamine beta 3 adrenergic agonistsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Mar 3, 1998·17 cites·16 claims
- 3463US5567597AHydrolytic enzyme inhibitors/inactivators and methods for using sameUNIV CALIFORNIA·Filed 1995·Granted Oct 22, 1996·17 cites·2 claims
- 3561US8563583B2Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonistsAHMAD SALEEM·Filed 2010·Granted Oct 22, 2013·1 cites·21 claims
- 3661US2009011994A1Non-basic melanin concentrating hormone receptor-1 antagonists and methodsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 3760US7342127B2Substituted anilide ligands for the thyroid receptorBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Mar 11, 2008·1 cites·23 claims
- 3858US5093239AReagents for detecting oxidase positive microorganismsEASTMAN KODAK CO·Filed 1988·Granted Mar 3, 1992·5 cites·3 claims
- 3955US5308766AHydrolytic enzyme inhibitors/inactivators and methods for using sameUNIV CALIFORNIA·Filed 1991·Granted May 3, 1994·21 cites·9 claims
- 4050US8754211B2Azolotriazinone melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 17, 2014·0 cites·13 claims
- 4149US4672029AColor-forming couplers and their use in the analytical determination of hydrogen peroxide or other analytesEASTMAN KODAK CO·Filed 1984·Granted Jun 9, 1987·11 cites·23 claims
- 4246US2003087843A1O-pyrazole glucoside SGLT2 inhibitors and method of useFiled 2002·Application pending·0 cites
- 4345US2004176425A1Cycloalkyl containing anilide ligands for the thyroid receptorFiled 2004·Application pending·0 cites
- 4445US2009220598A1Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor AgonistsGARG NEERAJ·Filed 2007·Application pending·0 cites
- 4544US9586900B2Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonistsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 7, 2017·0 cites·10 claims
- 4644US5254592AMultiply substituted anilines, phenols and pyridines-immunomodulating agentsSTERLING DRUG INC·Filed 1991·Granted Oct 19, 1993·2 cites·2 claims
- 4738US9062028B2Bicyclic nitrogen containing heteroaryl TGR5 receptor modulatorsROBL JEFFREY A·Filed 2012·Granted Jun 23, 2015·0 cites·14 claims
- 4836US4680356AColorless ligand-releasing monomers and polymers and their use to provide dyes with metal ionsEASTMAN KODAK CO·Filed 1985·Granted Jul 14, 1987·2 cites·5 claims
- 4930US5449691A3,4-disubstituted anilines-immunomodulating agentsSTERLING WINTHROP INC·Filed 1993·Granted Sep 12, 1995·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when William N. Washburn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →